Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

GSK has received approval from Japan's MHLW for its application to extend the indication of its RSV vaccine, Arexvy.

When you think of Carla Hall, delicious food, a friendly personality and distinctive eyewear may come to mind. But Hall, of Food Network, “The Chew” and “Top Chef” fame, is adding another role to her ...

GSK (GSK) announced that Japan’s Ministry of Health, Labour and Welfare, MHLW, has approved a regulatory application to extend the indication of Arexvy for the prevention of RSV disease to include ...

Japan’s MHLW grants expanded indication approval to GSK’s RSV vaccine, Arexvy for adults aged 50-59 at increased risk of severe RSV disease: London, UK Saturday, November 23, ...

(Alliance News) - GSK PLC said on Friday that Japan's Ministry of Health, Labour & Welfare has approved the expansion of its Arexvy respiratory syncytial virus vaccine to include adults aged 50 to 59 ...

Arexvy, which from September 2023 had been approved in Japan for adults 60 and over for the prevention of RSV disease, can ...

GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

(RTTNews) - GSK plc (GSK, GSK.L) announced that Japan's Ministry of Health, Labour and Welfare has approved a regulatory application to extend the indication of Arexvy for the prevention of RSV ...

A judge in the U.K. last month sided with Pfizer over GSK in a respiratory syncytial virus vaccine patent lawsuit, ...

One of the available vaccinations is AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted), an FDA-approved vaccine used to prevent lung and lower airway infection from RSV in people 60 years and ...

(Alliance News) - Stock prices in London closed lower, while equities in New York opened in the red after Federal Reserve Chair Jerome Powell dashed rate cut hopes overnight. The FTSE 100 index ...